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Should we use BMI as a selection criterion for bariatric surgery? 
 
Body Mass Index (BMI) is part of us. We grew up with it. We learnt it. We use it every day. We define 
obesity by it. We devise guidelines according to it. As such, BMI seems to have acquired an 
untouchable, almost mythical status since its conception by Quetellet in the 19th Century.  
BMI has been in use since 1985 as a clinical tool for patients with obesity following a National 
Institutes of Health Consensus (1). Use of BMI cut-off values as a selector for bariatric surgery was 
first introduced in 1991 (2). Despite the widely ubiquitous adoption and apparent acceptance of BMI 
as a clinically utilitarian variable, BMI is inherently flawed. If we want to understand the nature of 
obesity, and the inherent flaws associated with BMI as a concept, we need to step outside of the 
matrix. We need to challenge our own dogmatic beliefs and return to first principles. 
The rationale for BMI as a selection criterion for bariatric surgery stems from three fundamental 
principles. The first of these is that bariatric surgery is a limited resource. This is self-evidently true. 
Even if the number of bariatric surgical procedures was increased 10-fold, this would still only scrape 
the surface of the magnitude of the obesity epidemic. As such, bariatric surgery will never be a 
treatment option for obesity that is truly scalable to the population level. It is entirely appropriate 
(indeed essential) therefore that we select patients to undergo bariatric surgery.   
The second fundamental principle for using BMI as a selection criterion for bariatric surgery is that 
BMI reflects body fat content. Although this appears to be true for the population (3), BMI is less 
reliable on an individual level (4). People vary in their muscularity, and sarcopenia is common in the 
elderly. At the extremes of body habitus, BMI falls apart as a reliable measure of body fat content. 
Furthermore, given the scaling of body volume with the cubed exponent of height, BMI actually 
increases linearly with height, thereby introducing inaccuracies in patients at extremes of height (5). 
However, even if BMI was a perfect measure of body fat content, the cut-offs for defining obesity 
and the selection criteria for bariatric surgery are entirely arbitrary. Who can define what constitutes 
‘excessive adiposity’, a nebulous term that lacks clarity? Furthermore, ‘excessive adiposity’, however 
we define it is likely to vary between individuals based on biological complexity, and even within the 
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same individual over time. Additionally, BMI provides no indication of body fat distribution, an 
important indicator of cardiometabolic risk.  
The third fundamental principle for using BMI as a selection criterion for bariatric surgery is that 
‘excessive adiposity’ is harmful to health commensurately, and therefore underlies the co-morbidity 
of obesity. In other words, the total amount of body fat (reflected in BMI) is the best indicator of 
obesity-related co-morbidity, and therefore the best way to select for bariatric surgery. On a 
population level, it is broadly true that fat mass does indeed correlate with much obesity related co-
morbidity, such as glycaemic control, blood pressure and severity of obstructive sleep apnoea (6, 7). 
If we extrapolate these population-level association data to the individual however, we run into 
problems. In fact, on an individual level, body fat content per se is actually quite a poor indicator of 
obesity-related co-morbidity. As alluded to earlier, body fat distribution is important, with visceral 
fat conferring cardiometabolic risk, and gynoid fat even having a cardiovascular protective effect (8). 
Ectopic fat (hepatic, peri-cardiac and intramuscular) also confers metabolic risk (9). Furthermore, 
inflammatory status of adipose tissue is associated with insulin resistance and cardiometabolic risk 
(10). In short, multiple factors other than quantity of body fat influence cardiometabolic risk.  
There is inherent complexity in the pathogenesis of cardiometabolic risk that underlies a large 
proportion of the co-morbidity of obesity. Based on our current evidence, much of this complexity 
goes far beyond a simple reflection of body fat quantity. Furthermore, there is even evidence to 
show that improvement in mortality following bariatric surgery appears independent of weight-loss 
(and therefore BMI reduction) per se (11).  
It is logical to base selection criteria for bariatric surgery on degree of individual cardiometabolic risk, 
rather than on BMI and total body fat mass per se. The Edmonton Obesity Staging System (EOSS) is a 
clinical tool for obesity that incorporates obesity-related co-morbidities and functional limitations 
(12). It has been argued that EOSS could be used to select patients for bariatric surgery, although it is 
acknowledged that it is difficult currently to predict which patients at lower EOSS stages will 
progress to higher stages over time, and which will remain stable (13). Furthermore, the American 
Association of Clinical Endocrinologists (AACE) have published recommendations to recognize the 
need for a more robust and medically meaningful definition of obesity, and for management targets 
to include weight-related complications and quality of life (14).  
In many tier 3 settings within the NHS (National Health Service), multi-disciplinary management of 
obesity over a prolonged period enables some degree of assessment of suitability and candidacy for 
bariatric surgery (including clinical, biochemical and psychological factors) that goes beyond BMI. 
The fact remains however, that despite availability of more refined assessment tools for obesity such 
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as EOSS (12) and clear recommendations for refinement of definition and management targets for 
obesity from AACE (14), BMI remains a central pre-requisite for bariatric surgery selection in NICE 
guidelines and many other guidelines globally, even in cases of obesity-related co-morbidity. 
Therefore, some patients who should perhaps be eligible for bariatric surgery based on 
cardiometabolic risk face potential preclusion from this treatment option based on their BMI.    
In addition to consideration of current weight-related co-morbidities, refinement of selection criteria 
for bariatric surgery may also consider future risk of cardiometabolic risk. In a recent study on obese 
adults (n=474) from Poland, the risk for development of Type 2 Diabetes Mellitus (T2D) was shown 
to be influenced by serum adiponectin levels, age at onset of obesity and variants within the TCF7L2 
gene (15). In a further study from the same group, it was shown that although early-onset obesity 
(<age 20 years) was predictive of a higher BMI and total body fat, the risk of development of 
cardiometabolic complications (including hypertension and T2D) in this group was lower than in 
those with later, adult-onset obesity (16). Based on these data, perhaps future selection criteria for 
bariatric surgery should incorporate predictors of cardiometabolic complications that include age of 
obesity onset, genetic markers and adipokine profiles. 
In addition to cardiometabolic risk, selection for bariatric surgery should of course also consider 
psychological and emotional factors that may have a negative impact on the outcome of bariatric 
surgery. In one study, there were associations between insomnia, depression, appetite scores and 
daily consumption of snack foods (17). Whilst our own group did not demonstrate pre-operative 
psychological (and quality of life) factors as significant predictors of weight-loss following gastric 
band insertion (18), future studies on pre-operative predictors of outcome following bariatric 
surgery should further explore this area, and include measures of sleep quality and sufficiency, given 
the known effects of sleep duration on appetite control (19). Future guidelines on selection criteria 
for bariatric surgery should perhaps provide greater emphasis on psychological, emotional and 
lifestyle predictors of outcome: such guidance would also serve as means to optimize such factors 
prior to selection for bariatric surgery.    
Finally, further research should focus on development of future biomarkers for obesity-related 
cardiometabolic risk, and their potential utility as possible selection criteria for bariatric surgery. 
Based on current evidence linking inflammatory status within adipose tissue and association with 
T2D and cardiometabolic risk (10), clinically available and reliable biomarkers of adipose tissue 
inflammation would be of potential interest. Furthermore, given the central role of cardiorespiratory 
fitness as a determinant of cardiometabolic risk (20), development of clinically accessible and 
reliable biomarkers of cardiorespiratory fitness would have clinical utility. Although speculative, it is 
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possible that such measures of cardiorespiratory fitness could inform candidacy for bariatric surgery 
based on cardiometabolic risk, although this would require supportive evidence prior to guideline 
implementation.  
Perhaps one reason for the persistence of BMI as a selection criterion for bariatric surgery stems 
from its utility on a population level as a measure of body fat mass (3). From the perspective of 
policy-makers and guideline-drafters, BMI therefore may appear to have utility as a means of 
stratifying the populace, based on population-wide body fat mass and therefore perceived need. 
However, future guidelines for bariatric surgery should move beyond BMI, and consider the wider 
picture from the clinical needs of the individual patient perspective, rather than from a populace 
viewpoint. In re-defining eligibility for bariatric surgery, we may also transform the way we think 
about obesity and its importance as a clinical entity. Not so much as a condition of excessive 
adiposity, but as a condition with weight-related (primarily cardiometabolic) comorbidities centre 
stage.     
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